Mount Carmel Health Partners Clinical Guidelines Hyperlipidemia | Page 6

ICD-10 Codes - Hyperlipidemia
ICD 10

Description

I25.10

Atherosclerotic heart disease of native coronary artery without angina pectoris

I25.11

Atherosclerotic heart disease of native coronary artery with angina pectoris

E78.0

Pure hypercholesterolemia

E78.1

Pure hyperglyceridemia

E78.2

Mixed hyperlipidemia

E78.4

Other hyperlipidemia

E78.5

Hyperlipidemia, unspecified

Note: These are the most commonly used ICD codes.

References:
1. ADA 2014 Guidelines: Management of Dyslipidemia. Accessed from http://www.ndei.org/dsl/newslide.aspx?Slideid=3323.
2. Food and Drug Administration. Overview of dietary supplements. http://www.fda.gov/Food/DietarySupplements/ConsumerInformation/ucm110417.htm.
Updated October 14, 2009. Accessed October 16, 2009.
3. Blaha, Michael J. The Critical Importance of Risk Score Calibration. Ibid. p. 2131-2134.
4. FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs (Feb 28, 2012) (http://www.fda.gov/Drugs/Drug Safety/
ucm2983101.htm)
5. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/
American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63: 2960–84
6. Jacobson TA, Maki KC, Orringer CE, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2. J Clin Lipidol.
2015;9:S1–122.
7. PL Detail-Document, 2013 ACC/AHA Cholesterol Guidelines. Pharmacist’s Letter/Prescriber’s Letter. January 2014.
8. Rana, Jamal et al. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. (Journal of the American College
of Cardiology 2016. Volume 67, Issue 18, p. 2118-2130).
9. Statin Intolerance: Reconciling Clinical Trials and Clinical Experience (JAMA March 10, 2015 Volume 313, Number 10, p. 1011-1012).
10. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST,
Smith SC Jr, Watson K, Wilson PWF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report
of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(suppl 2):S1–S45.
11. Up-To-Date. Treatment of lipids (including hypercholesterolemia) in secondary prevention. 2015.
12. Up-To-Date; atp///guidelines for treatment of high blood cholesterol. 2014.
13. Up-To-Date. Statins: Action, side effects, and administration. 2016.

This clinical guideline outlines the recommendations of Mount Carmel Health Partners for this medical condition and is based upon the referenced best practices. It is
not intended to serve as a substitute for professional medical judgment in the diagnosis and treatment of a particular patient. Decisions regarding care are subject to
individual consideration and should be made by the patient and treating physician in concert.

Original Issue Date: November 2011

Revision Dates: February 2013, December 2014, March 2015, August 2016

Hyperlipidemia - 6